AVCNF
Price:
$0.186
Market Cap:
$28.49M
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
AVCNF
According to Avicanna Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.66. This represents a change of -65.12% compared to the average of -7.63 of the last 4 quarters.
The mean historical PE Ratio of Avicanna Inc. over the last ten years is -173.04. The current -2.66 PE Ratio has changed 53.72% with respect to the historical average. Over the past ten years (40 quarters), AVCNF's PE Ratio was at its highest in in the December 2020 quarter at -0.68. The PE Ratio was at its lowest in in the March 2018 quarter at -75.88.
Average
-173.04
Median
-2.94
Minimum
-1347.59
Maximum
-1.13
Discovering the peaks and valleys of Avicanna Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.70%
Maximum Annual PE Ratio = -1.13
Minimum Annual Increase = -98.66%
Minimum Annual PE Ratio = -1347.59
Year | PE Ratio | Change |
---|---|---|
2023 | -3.44 | 162.70% |
2022 | -1.31 | -36.24% |
2021 | -2.05 | 82.42% |
2020 | -1.13 | -53.94% |
2019 | -2.44 | -70.44% |
2018 | -8.27 | -54.26% |
2017 | -18.08 | -98.66% |
The current PE Ratio of Avicanna Inc. (AVCNF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.27
5-year avg
-2.08
10-year avg
-173.04
Avicanna Inc.’s PE Ratio is less than PharmaCielo Ltd. (-1.07), less than Khiron Life Sciences Corp. (-0.00), less than Flower One Holdings Inc. (0), less than Cansortium Inc. (-1.90), less than 4Front Ventures Corp. (-0.73),
Company | PE Ratio | Market cap |
---|---|---|
-1.07 | $9.06M | |
-0.00 | $514.31M | |
0 | $1.75M | |
-1.90 | $32.15M | |
-0.73 | $25.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avicanna Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avicanna Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Avicanna Inc.'s PE Ratio?
How is the PE Ratio calculated for Avicanna Inc. (AVCNF)?
What is the highest PE Ratio for Avicanna Inc. (AVCNF)?
What is the 3-year average PE Ratio for Avicanna Inc. (AVCNF)?
What is the 5-year average PE Ratio for Avicanna Inc. (AVCNF)?
How does the current PE Ratio for Avicanna Inc. (AVCNF) compare to its historical average?